ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $1,187,000 | -0.7% | 1,099,525 | -4.3% | 0.00% | 0.0% |
Q2 2014 | $1,195,000 | -4.8% | 1,149,255 | -5.7% | 0.00% | 0.0% |
Q1 2014 | $1,255,000 | -12.5% | 1,218,697 | -1.4% | 0.00% | 0.0% |
Q4 2013 | $1,434,000 | -32.9% | 1,236,510 | -2.8% | 0.00% | -50.0% |
Q3 2013 | $2,138,000 | -16.3% | 1,272,487 | -0.3% | 0.00% | 0.0% |
Q2 2013 | $2,553,000 | – | 1,276,647 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
NEXT Financial Group, Inc | 60 | $0 | 0.00% |
CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |